Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2
Fangjian Guo
,
Victor Adekanmbi
,
Christine D. Hsu
, Efstathia Polychronopoulou
,
Abbey B. Berenson
Obstetrics & Gynecology
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
COVID-19
100%
One Dose
100%
Two-dose
100%
Breakthrough Infection
100%
COVID-19 Vaccine
100%
Infection Risk
40%
Vaccine Dose
40%
Reinfection
20%
Revaccination
20%
Age Categories
20%
Between-person
20%
Confounding Factors
20%
Racial-ethnic Groups
20%
Vaccine Types
20%
Propensity Score
20%
Optum
20%
Electronic Health Record Data
20%
SARS-CoV-2 Reinfection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Severe Acute Respiratory Syndrome
100%
COVID-19 Vaccine
100%
Reinfection
40%
SARS Coronavirus
20%
Immunology and Microbiology
Severe Acute Respiratory Syndrome
100%
COVID-19
100%
Breakthrough Infection
100%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Electronic Health Record
20%
Mathematics
Confounding Factor
100%